BTIG analyst Lance Jessurun reaffirmed a Neutral rating on PayPal (NASDAQ:PYPL) stock, expressing caution ahead of the ...

BTIG analyst Carl Reichardt Jr. maintained a Neutral rating on shares of NVR Inc . (NYSE:NVR), while slightly lowering ...

In a report released today, Julian Harrison from BTIG maintained a Buy rating on Cullinan Management (CGEM – Research Report), with a price ...

BTIG analyst Vincent Caintic maintained a Buy rating on Affirm Holdings (AFRM – Research Report) yesterday and set a price target of $81.00.

Market technician Jonathan Krinsky analyzes the shift in market leadership from technology to healthcare amid recent ...

BTIG raised the firm’s price target on Intuitive Surgical (ISRG) to $622 from $561 and keeps a Buy rating on the shares after ...

What damage might Monday's ongoing selloff do to the technical set-up for stocks? Well, in a note published on Sunday, BTIG chartist guru Jonathan Krinsky observed that Friday's action had already sug ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the ...

Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...

BTIG Research began coverage on shares of Arcturus Therapeutics (NASDAQ:ARCT – Get Free Report) in a research report issued on Tuesday, MarketBeat reports. The brokerage set a “buy” rating and a ...

BTIG lowered the firm’s price target on Evolent Health (EVH) to $20 from $29 but keeps a Buy rating on the shares. The firm ...

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, toda ...